GSK to acquire 35Pharma for USD950m to strengthen cardiopulmonary pipeline

SoftOx secures Irish approval for Phase 1 trial of SIS-02

Avid Bioservices opens new Early Phase Center of Excellence

OrthoTrophix completes patient enrolment in TPX-100 Phase 2b clinical trial

Bloom Science doses first patient in Phase 1b trial of BL-001 for obesity treatment

Johnson & Johnson submits sBLA to FDA for first-ever treatment for wAIHA

Epredia signs EU distribution deal with Mindpeak for AI pathology software

AlzeCure's ACD440 granted EU orphan drug status for erythromelalgia

Armata Pharmaceuticals' AP-SA02 receives QIDP designation from US FDA

Astellas Pharma signs global strategic collaboration with Vir Biotechnology

Illumina sets out 18-Month NovaSeq X roadmap to boost sequencing performance and scale

Gossamer Bio reports topline Phase 3 PROSERA results for seralutinib in PAH

Novo Nordisk's CagriSema achieves 23% weight loss but misses primary endpoint in REDEFINE 4 trial

NICE recommends epcoritamab for relapsed or refractory follicular lymphoma

AbbVie's VENCLEXTA (venetoclax) and acalabrutinib combination receives US FDA approval to treat CLL